SCHEMBL8206418

SCHEMBL8206418

COc1ccc(-c2cn(-c3ccccc3)nc2N)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 6/20 0.70
RAB9A P51151 4/20 0.68
MEN1 O00255 4/20 0.66
KMT2A Q03164 4/20 0.66
KDM4E B2RXH2 2/20 0.66
SMN1; SMN2 Q16637 2/20 0.66
NPC1 O15118 2/20 0.66
ALDH1A1 P00352 2/20 0.66
MAPT P10636 1/20 0.66
ADORA3 P0DMS8 3/20 0.60
HTT P42858 1/20 0.58
L3MBTL1 Q9Y468 2/20 0.54
NLRP3 Q96P20 1/20 0.54
ATM Q13315 1/20 0.54
ABL1 P00519 1/20 0.53
EGFR P00533 1/20 0.53
SRC P12931 1/20 0.53
KDR P35968 1/20 0.53
ABL2 P42684 1/20 0.53
ADORA2A P29274 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10417253 0.86 MAPKAPK2 (0.70) MAPKAPK2RAB9AMEN1KMT2AKDM4E
SCHEMBL3852847 0.84 RAB9A (0.58) MAPKAPK2RAB9AMEN1KMT2AKDM4E
SCHEMBL11837756 0.82 RAB9A (0.72) MAPKAPK2RAB9AMEN1KMT2AKDM4E
SCHEMBL11766305 0.81 RAB9A (1.00) MAPKAPK2RAB9AMEN1KMT2AKDM4E
SCHEMBL8206667 0.80 NPC1 (0.58) RAB9AMEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL11765458 0.80 RAB9A (0.82) MAPKAPK2RAB9AMEN1KMT2AKDM4E
SCHEMBL4186718 0.79 RAB9A (0.65) RAB9AMEN1KMT2AKDM4ESMN1; SMN2
SCHEMBL17619706 0.78 PTGS2 (0.51) MAPKAPK2RAB9AMEN1KMT2AKDM4E
SCHEMBL11762985 0.77 RAB9A (0.81) MAPKAPK2RAB9AMEN1KMT2AKDM4E
SCHEMBL11037574 0.77 MAPKAPK2 (0.61) MAPKAPK2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008046527-A1 ACYLAMINOPYRAZOLES FOR TREATING CARDIOVASCULAR DISEASES BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-04-24 WO disclosed